Solu-Medrol
Showing 1 - 25 of 136
Lymphoma, Non-Hodgkin Trial in Saint Louis (Stem cell infusion, TLI, Anti-thymocyte globulin)
Active, not recruiting
- Lymphoma, Non-Hodgkin
- Stem cell infusion
- +5 more
-
Saint Louis, MissouriWashington University
Jan 17, 2023
Systemic Lupus Erythematous (SLE) Trial run by the NIAMS (SOLU-MEDROL)
Recruiting
- Systemic Lupus Erythematous (SLE)
- SOLU-MEDROL
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Myocarditis Acute Trial (Methylprednisolone 125 MG [Solu-Medrol], IV saline solution 250 mL [Placebo])
Not yet recruiting
- Myocarditis Acute
- Methylprednisolone 125 MG [Solu-Medrol]
- IV saline solution 250 mL [Placebo]
- (no location specified)
Aug 3, 2023
Toxic Epidermal Necrolysis Trial in Fuzhou (Abrocitinib)
Recruiting
- Toxic Epidermal Necrolysis
-
Fuzhou, Fujian, ChinaDepartment of Dermatology, the First Affiliated Hospital of Fuji
Oct 31, 2023
Normal Physiology Trial run by the NIAID (Methylprednisolone sodium succinate(Solu-Medrol), Topical methylprednisolone (Advantan
Completed
- Normal Physiology
- Methylprednisolone sodium succinate(Solu-Medrol)
- Topical methylprednisolone (Advantan emulsion 0 /1%)
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Nov 18, 2022
Ulcerative Colitis Acute Trial in Ann Arbor (Cyclosporine Injection (IV), Cyclosporine Oral Product, Upadacitinib Extended
Not yet recruiting
- Ulcerative Colitis Acute
- Cyclosporine Injection (IV)
- +4 more
-
Ann Arbor, MichiganUniversity of Michigan
May 6, 2023
Leukemia Trial in Portland (cyclophosphamide, cytarabine, dexamethasone)
Terminated
- Leukemia
- cyclophosphamide
- +8 more
-
Portland, OregonOHSU Knight Cancer Institute
Dec 13, 2022
ST Elevation Myocardial Infarction, Inflammatory Response, Myocardial Reperfusion Injury Trial (Methylprednisolone, Isotonic
Not yet recruiting
- ST Elevation Myocardial Infarction
- +3 more
- Methylprednisolone
- Isotonic saline
- (no location specified)
Aug 4, 2022
Hepatitis, Drug-Induced Trial in Denmark (Mycophenolate Mofetil, Tacrolimus, Solu-Medrol)
Recruiting
- Hepatitis, Drug-Induced
- Mycophenolate Mofetil
- +3 more
-
Herlev, Copenhagen, Denmark
- +4 more
Dec 11, 2022
Thyroid-Associated Ophthalmopathy Trial (Sirolimus 1 mg Oral Tablet, Methylprednisolone)
Not yet recruiting
- Thyroid-Associated Ophthalmopathy
- Sirolimus 1 mg Oral Tablet
- Methylprednisolone
- (no location specified)
Mar 18, 2022
Orthopedic Surgeries Trial in Atlanta (10 mg IV dexamethasone & 6 day oral methylprednisolone taper, 10 mg IV dexamethasone)
Enrolling by invitation
- Orthopedic Surgeries
- 10 mg IV dexamethasone & 6 day oral methylprednisolone taper
- 10 mg IV dexamethasone
-
Atlanta, Georgia
- +2 more
Feb 25, 2022
Crohn Disease Trial in Los Angeles (drug, procedure, biological)
Recruiting
- Crohn Disease
- Mesna
- +12 more
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Mar 23, 2022
Out-Of-Hospital Cardiac Arrest, Cardiac Arrest, Cardiac Arrest With Successful Resuscitation Trial in Copenhagen, Gentofte
Active, not recruiting
- Out-Of-Hospital Cardiac Arrest
- +5 more
- Methylprednisolone
- Isotonic saline
-
Copenhagen, Denmark
- +1 more
Nov 6, 2022
Covid19 Trial in Assiut (Dexamethasone, Methylprednisolone)
Completed
- Covid19
-
Assiut, Assuit, EgyptAssiut university hospital
Sep 4, 2021
Acute Liver Failure, Fulminant Hepatic Failure, Hepatic Encephalopathy Trial in United States (High-dose methylprednisolone,
Recruiting
- Acute Liver Failure
- +4 more
- High-dose methylprednisolone
- +6 more
-
Los Angeles, California
- +19 more
Dec 5, 2022
Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (Nivolumab, Idarubicin, Cytarabine)
Completed
- Leukemia
- +2 more
- Nivolumab
- +4 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 9, 2021
Contiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Stage I Adult
Completed
- Contiguous Stage II Adult Lymphoblastic Lymphoma
- +5 more
- carfilzomib
- +10 more
-
Sacramento, CaliforniaUniversity of California Davis
Mar 8, 2022
Complications Trial in Calgary (Methylprednisolone, Placebo)
Completed
- Complications
- Methylprednisolone
- Placebo
-
Calgary, Alberta, CanadaFoothills Medical Centre
Apr 27, 2021
Carpal Tunnel Syndrome Trial in Boardman (Methylprednisolone Injection [Solu-Medrol], wrist splint)
Recruiting
- Carpal Tunnel Syndrome
- Methylprednisolone Injection [Solu-Medrol]
- wrist splint
-
Boardman, OhioSt. Elizabeth Boardman Family Medicine
Sep 1, 2021
Hand Injuries, Finger Injuries Trial in Brick, Somerset (Methylprednisolone Tablet, Standard Mobilization Treatment)
Not yet recruiting
- Hand Injuries
- Finger Injuries
- Methylprednisolone Tablet
- Standard Mobilization Treatment
-
Brick, New Jersey
- +1 more
Aug 5, 2021
Multiple Myeloma Trial in United States (Ruxolitinib Oral Tablet [Jakafi], Lenalidomide, Methylprednisolone)
Recruiting
- Multiple Myeloma
- Ruxolitinib Oral Tablet [Jakafi]
- +2 more
-
Alhambra, California
- +12 more
Apr 18, 2022
Covid19, SARS-CoV Infection, Pneumonia, Viral Trial in Modena (Enoxaparin, Methylprednisolone, unfractionated heparin)
Recruiting
- Covid19
- +3 more
- Enoxaparin
- +2 more
-
Modena, ItalyICU- University Hospital Modena
May 3, 2021
Kidney Transplant Trial in Canada, United States (Infliximab, Methylprednisolone, Mycophenolate Mofetil)
Completed
- Kidney Transplant
- Infliximab
- +9 more
-
Birmingham, Alabama
- +14 more
Jul 19, 2022